Detalhe da pesquisa
1.
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
Cell
; 185(20): 3705-3719.e14, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179667
2.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med
; 388(25): 2338-2348, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342922
3.
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
Blood
; 141(12): 1389-1401, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399701
4.
Patient-reported treatment response in chronic graft-versus-host disease.
Haematologica
; 109(1): 143-150, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226713
5.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
6.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
7.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
8.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
9.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438043
10.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Biol Blood Marrow Transplant
; 26(4): 665-671, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881283
11.
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Cancer
; 126(10): 2183-2192, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101640
12.
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer
; 126(10): 2193-2205, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125707
13.
Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 25(4): 800-809, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30521974
14.
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.
Biol Blood Marrow Transplant
; 25(3): 599-605, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296479
15.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153491
16.
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(7): 1514-1520, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448058
17.
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.
Biol Blood Marrow Transplant
; 24(6): 1274-1280, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325830
18.
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.
Blood
; 128(10): 1346-61, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439912
19.
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.
Haematologica
; 103(11): 1915-1924, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954931
20.
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 23(7): 1059-1063, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389254